BioCryst Pharmaceuticals, Inc.
USD9.42
+0.31 (+3.40%)
CEO
Charles K. Gayer
IPO Date
1994-03-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$9.20
Prev. Close
$9.11
Day Low
$9.10
Day High
$9.42
52W Low
$6.00
52W High
$11.22
Market Cap
$1.98B
Volume
2.24M
| 33,540 |
| $8.50 |
| 15 Jun 2026 | Galson Steven K | director | A-Award | Acquired | 15,294 | $0.00 |
| 15 Jun 2026 | Galson Steven K | director | A-Award | Acquired | 33,540 | $8.50 |
| 15 Jun 2026 | LEVIN ALAN G | director | A-Award | Acquired | 15,294 | $0.00 |
| 15 Jun 2026 | LEVIN ALAN G | director | A-Award | Acquired | 33,540 | $8.50 |
| 15 Jun 2026 | Frank Steven | director | A-Award | Acquired | 15,294 | $0.00 |
| 15 Jun 2026 | Frank Steven | director | A-Award | Acquired | 33,540 | $8.50 |
| 15 Jun 2026 | SANDERS MACHELLE | director | A-Award | Acquired | 15,294 | $0.00 |
| 15 Jun 2026 | SANDERS MACHELLE | director | A-Award | Acquired | 33,540 | $8.50 |
| $1,001 - $15,000 |
| 16 Sept 2022 | Josh Gottheimer | Josh Gottheimer | Purchase | $1,001 - $15,000 |